Association of specific genotypes in metastatic suppressor HTPAP with tumor metastasis and clinical prognosis in hepatocellular carcinoma

Cancer Research

Volumn 71, Issue 9, 2011, Pages 3278-3286

  Ren, Ning ^a   Wu, Jin Cai ^a   Dong, Qiong Zhu ^a   Sun, Hai Jing ^a   Jia, Hu Liang ^a   Li, Guo Cai ^a   Sun, Bing Sheng ^a   Dai, Chun ^a   Shi, Jiong ^a   Wei, Jin Wang ^a   Sheng, Yuan Yuan ^a   Zhou, Hai Jun ^a   Ye, Qing Hai ^a   Qin, Lun Xiu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; PHOSPHATIDATE PHOSPHATASE; TOLL LIKE RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INTERLEUKIN 8 GENE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 2 GENE;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; GENOTYPE; HAPLOTYPES; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; PHOSPHATIDATE PHOSPHATASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RNA, MESSENGER;

EID: 79955488324     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3100     Document Type: Article

References (41)

1. Qin LX, Tang ZY, Sham JS, Ma ZC, Ye SL, Zhou XD, et al. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 1999;59:5662-5.
2. Qin LX, Tang ZY, Ye SL, Liu YK, Ma ZC, Zhou XD, et al. Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared. J Cancer Res Clin Oncol 2001;127:482-8.
3. Pang JZ, Qin LX, Ren N, Hei ZY, Ye QH, Jia WD, et al. Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma. Clin Cancer Res 2007;13:7363-9.
4. Ren N, Qin LX, Tu H, Liu YK, Zhang BH, Tang ZY, et al. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2006;132:399-407.
5. Wu X, Jia HL, Wang YF, Ren N, Ye QH, Sun HC, et al. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma. Oncogene 2006;25:1832-40.
6. Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H, et al. A 1Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes. Oncogene 2005;24:5235-45. (Pubitemid 41192440)
7. Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, et al. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res 2008;68:7165-75.
8. Jenssen TK, Kuo WP, Stokke T, Hovig E. Associations between gene expressions in breast cancer and patient survival. Hum Genet 2002;111:411-20. (Pubitemid 36075070)
9. Sun T, Gao Y, Tan W, Ma S, Shi Y, Yao J, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 2007;39: 605-13. (Pubitemid 46676113)
10. Kong SY, Park JW, Lee JA, Park JE, Park KW, Hong EK, et al. Association between vascular endothelial growth factor gene polymorphism and survival in hepatocellular carcinoma patients. Hepatology 2007;46:446-55.
11. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008;100:698-711.
12. National Center for Biotechnology Information [Internet]. Bethesda: Single Nucleotide Polymorphism. [cited 2008 Feb 1]. Available from: http://www.ncbi.nlm.nih.gov/projects/SNP.
13. National Center for Biotechnology Information [Internet]. Bethesda: Basic Local Alignment search tool. [cited 2008 Feb 1]. Available from: http://blast.ncbi.nlm.nih.gov/Blast.cgi.
14. Broad Institute [Internet]. Cambridge: Haploview. [cited 2008 May 1]. Available from: http://www.broad.mit.edu/mpg/haploview.
15. Department of Statistics at University of Washington [Internet]. Seattle: PHASE: software for haplotype reconstruction, and recombination rate estimation from population data. [cited 2008 May 1]. Available from: http://www.stat. washington.edu/stephens/software.html.
16. Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, et al. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the multiethnic cohort study. Hum Hered 2003;55:27-36. (Pubitemid 36928743)
17. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-29. (Pubitemid 34680308)
18. Stram DO. Tag SNP selection for association studies. Genet Epidemiol 2004;27:365-74. (Pubitemid 39602320)
19. de Bakker PI, Burtt NP, Graham RR, Guiducci C, Yelensky R, Drake JA, et al. Transferability of tag SNPs in genetic association studies in multiple populations. Nat Genet 2006;38:1298-303. (Pubitemid 44646292)
20. Department of Statistics at Stanford University [Internet]. Stanford: SAM: Significance Analysis of Microarrays. [Updated 2007 Jan 23; cited 2009 Mar 1]. Available from: http://www-stat.stanford.edu/~tibs/ SAM.
21. Howard Hughes Medical Institute at University of California [Internet]. Berkeley: Cluster Analysis and Visualization. [Updated 2002 Dec 6; cited 2009 Mar 1]. Available from: http://rana.lbl.gov/EisenSoftware. htm.
22. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23.
23. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
24. Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 2003;9:416-23. (Pubitemid 36460075)
25. Adler KB, Fischer BM, Wright DT, Cohn LA, Becker S. Interactions between respiratory epithelial cells and cytokines: relationships to lung inflammation. Ann N Y Acad Sci 1994;725:128-45. (Pubitemid 24222041)
26. Rolfe MW, Kunkel SL, Standiford TJ, Chensue SW, Allen RM, Evanoff HL, et al. Pulmonary fibroblast expression of interleukin-8: a model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol 1991;5:493-501.
27. Manna SK, Ramesh GT. Interleukin-8 induces nuclear transcription factor-kB through a TRAF6-dependent pathway. J Biol Chem 2005;280:7010-21. (Pubitemid 40341257)
28. Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, et al. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 2007;46:823-30. (Pubitemid 47436129)
29. Ren Y, Poon RT, Tsui HT, Chen WH, Li Z, Lau C, et al. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Clin Cancer Res 2003;9:5996-6001. (Pubitemid 38018086)
30. Kubo F, Ueno S, Hiwatashi K, Sakoda M, Kawaida K, Nuruki K, et al. Interleukin 8 in human hepatocellular carcinoma correlates with cancer cell invasion of vessels but not with tumor angiogenesis. Ann Surg Oncol 2005;12:800-7. (Pubitemid 41355932)
31. Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 2006;10:99-111. (Pubitemid 44202603)
32. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007;25:2586-93. (Pubitemid 47041232)
33. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immun 2003;170:508-19.
34. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004;279:7370-77. (Pubitemid 38294612)
35. Moriyama M, Matsumura H, Shioda J, Aoki H, Nakamura H, Arakawa Y, et al. Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis. Intervirology 2006;49:327-38. (Pubitemid 44543598)
36. Sun JJ, Zhou XD, Liu YK, Tang ZY, Feng JX, Zhou G, et al. Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1. Cancer Res Clin Oncol 1999;125:28-34. (Pubitemid 29062333)
37. Wu FX, Wang Q, Zhang ZM, Huang S, Yuan WP, Liu JY, et al. Identifying serological biomarkers of hepatocellular carcinoma using surface-enhanced laser desorption/ionization-time-of-flight mass spectroscopy. Cancer Lett 2009;279:163-70.
38. Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, et al. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology 2009;50:1484-93.
39. Tang L, Dai DL, Su M, Martinka M, Li G, Zhou Y. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res 2006;12:3716-22. (Pubitemid 44000252)
40. Yang SF, Yeh YT, Wang SN, Hung SC, Chen WT, Huang CH, et al. SOCS-3 is associated with vascular invasion and overall survival in hepatocellular carcinoma. Pathology 2008;40:558-63.
41. Riehle KJ, Campbell JS, McMahan RS, Johnson MM, Beyer RP, Bammler TK, et al. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med 2008;205:91-103. (Pubitemid 351185718)